Related Experiment Video
Updated: Sep 13, 2025

Polar Histogram Visualization of Acute Stress Disorder Scale Scores for Comprehensive Clinical Assessment
Published on: December 6, 2024
Clinical, thyroid metabolic, and inflammatory features in pediatric patients with post-acute COVID-19
Ping Yin1, Dongqing Zhang1, Baomin Li1
1Department of Pediatrics, Qilu Hospital of Shandong University, #107 West Wenhua Road, Jinan, Shandong, 250012, China.
Insights
Pediatric neuropsychiatric disorders post-COVID-19 (NP-COVID-19) are linked to low thyroid hormone (T3) syndrome and elevated cerebrospinal fluid (CSF) interleukin-8, not systemic inflammation.
Area of Science:
- Pediatric neurology
- Infectious diseases
- Neuroimmunology
Background:
- Children face increased risk of neuropsychiatric disorders after COVID-19.
- Limited data exists on clinical, metabolic, and CSF profiles in pediatric NP-COVID-19.
- This study investigated 13 pediatric patients with NP-COVID-19.
Purpose of the Study:
- To describe clinical features of pediatric NP-COVID-19.
- To assess metabolic and inflammatory profiles in NP-COVID-19 patients.
- To compare NP-COVID-19 patients with healthy and migraine controls.
Main Methods:
- Retrospective analysis of 13 pediatric NP-COVID-19 patients.
- Comparison of metabolic and inflammatory markers with healthy children (HC) and pre-pandemic migraine patients.
- Assessment of blood-brain barrier (BBB) integrity and CSF biomarkers.
Main Results:
- No significant systemic inflammation or differences in inflammatory parameters between NP-COVID-19 patients and HC.
- Elevated CSF interleukin-8 (IL-8) in NP-COVID-19 patients with intact BBB integrity compared to migraine controls.
- Lower serum free triiodothyronine (FT3) levels in NP-COVID-19 patients, with low-T3 syndrome in 61.5%.
Conclusions:
- Systemic inflammation is uncommon in pediatric NP-COVID-19.
- Low-T3 syndrome is prevalent in pediatric NP-COVID-19.
- Neuroinflammation in pediatric NP-COVID-19 is characterized by elevated CSF IL-8.
Background:
Children are at increased risk for neuropsychiatric disorders following COVID-19. However, information regarding the clinical, metabolic, and cerebrospinal fluid (CSF) characteristics in patients with neuropsychiatric disorders associated with COVID-19 is limited. In this study, we described the clinical features and retrospectively assessed the metabolic and inflammatory profiles of 13 pediatric patients who exhibited subacute neuropsychiatric symptoms within one month of SARS-CoV-2 infection (NP-COVID-19).
Methods:
We retrospectively reviewed and analyzed the clinical and paraclinical data of 13 children with NP-COVID-19 admitted to Qilu hospital from December 15, 2022, to January 31, 2023. Healthy children (HC, n = 21) and pre-pandemic migraine patients (n = 12) were included as controls. Systemic metabolic and inflammatory parameters in NP-COVID-19 patients including thyroid hormone levels and neutrophil-to-lymphocyte ratio were compared with HC. Blood-brain barrier (BBB) integrity and CSF biomarkers of intrathecal inflammation including cytokines and immunoglobulin G index were compared with migraine patients.
Results:
CSF SARS-CoV-2 RNA was negative in all patients with NP-COVID-19. No differences in systemic inflammatory parameters were found between NP-COVID-19 patients and HC. However, NP-COVID-19 patients with intact BBB integrity exhibited significantly higher CSF interleukin (IL)-8 levels than migraine controls. In addition, serum free triiodothyronine (FT3) levels were lower in NP-COVID-19 patients than HC and low-T3 syndrome occurred in 61.5% of NP-COVID-19 children.
Conclusions:
Systemic inflammation rarely occurred in children with NP-COVID-19. Low-T3 syndrome is prevalent in NP-COVID-19 pediatric patients and the neuroinflammatory activation is mainly characterized by elevated CSF IL-8. Further study is required to investigate the pathophysiologic mechanisms in NP-COVID-19.
More Related Videos
07:01A Pediatric Concussion Model in Mice: Closed Head Injury with Long-Term Disorders (CHILD)
Published on: February 7, 2025
10:02Event Related Potentials ERPs and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder ADHD
Published on: March 12, 2020
Related Concept Videos
Myocarditis II: Clinical Features and Diagnostic Tests
Attention-Deficit/Hyperactivity Disorder
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
Chronic Kidney Disease II: Clinical Manifestations
Depression: Overview
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Negative and Cognitive Symptoms of Schizophrenia
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...